Tagged: braingaze

Exclusive: Bioprognos CEO Sergio Calleja Discusses Crowdfunding with Spanish Platform Capital Cell

Bioprognos, a Barcelona-based biotech company that seeks to improve both clinical outcomes and quality of life for cancer patients ―as well as other diseases (cardiovascular, neurological or endocrine)― through the development of innovative tools for non-invasive, accurate detection from biomarkers found in a simple blood… Read More

Send this to a friend